Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
DPC 2024
Programm
Suche
DE
Alle Personen
Mr. Steffen Keller
Freiburg / DE
Uniklinik Freiburg
Sortiert nach Typ
Datum
Vortrag
Sa, 17.02.
11:50
–
11:55
3 Min.
2 Min.
ePoster presentation
P75
Implications of targeted SHP2-inhibition +/- MAPK-inhibition on cancer-associated fibroblasts in pancreatic cancer
Tumour microenvironment, epigenetics and stem cells
Weitere Beteiligungen
Do, 15.02.
16:40
–
16:45
3 Min.
2 Min.
ePoster presentation
P20
Mechanisms of resistance to targeted SHP2-inhibition +/- MAPK- or KRAS
G12D
-inhibition in pancreatic cancer
Pancreatic cancer
Do, 15.02.
18:10
–
18:20
8 Min.
2 Min.
Oral presentation
O17
Tumor-immune-microenvironmental implications of targeted SHP2-inhibition +/- MAPK-inhibition in pancreatic cancer
Pancreatic cancer
Sa, 17.02.
10:50
–
10:55
3 Min.
2 Min.
ePoster presentation
P54
Impact of targeted SHP2-inhibition +/- MAPK-Inhibition on metabolic rewiring in pancreatic cancer
Pancreatic cancer
Sa, 17.02.
11:50
–
11:55
3 Min.
2 Min.
ePoster presentation
P75
Implications of targeted SHP2-inhibition +/- MAPK-inhibition on cancer-associated fibroblasts in pancreatic cancer
Tumour microenvironment, epigenetics and stem cells
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz